2012
DOI: 10.1016/j.athoracsur.2012.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Results of Long-Term Follow-Up of Patients With Completely Resected Non-Small Cell Lung Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
52
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 69 publications
(53 citation statements)
references
References 22 publications
0
52
1
Order By: Relevance
“…The most common site of extrathoracic distant metastasis is the brain [1], detecting in approximately 30-55% in an autopsy series of patients with non-small-cell lung cancer (NSCLC) [2]. The prognosis of patients with brain metastasis is poor with a median survival of less than 1 year [3][4][5]. The reason for the poor prognosis of these patients is that brain metastases usually occur late in the course of the disease, often simultaneously with wide-spread systemic metastases [6].…”
Section: Introductionmentioning
confidence: 99%
“…The most common site of extrathoracic distant metastasis is the brain [1], detecting in approximately 30-55% in an autopsy series of patients with non-small-cell lung cancer (NSCLC) [2]. The prognosis of patients with brain metastasis is poor with a median survival of less than 1 year [3][4][5]. The reason for the poor prognosis of these patients is that brain metastases usually occur late in the course of the disease, often simultaneously with wide-spread systemic metastases [6].…”
Section: Introductionmentioning
confidence: 99%
“…Although most recurrences are intrathoracic, up to one-third are extrathoracic recurrences. The latter group is unlikely to benefit from thoracic surveillance imaging (6,(29)(30)(31). Each annual surveillance CT scan adds approximately $1,412 to the cost of additional investigation without affecting outcomes (32).…”
Section: Original Researchmentioning
confidence: 99%
“…Several studies have demonstrated the outcomes and predictive factors for the post-recurrence survival in resected NSCLC patients [3][4][5][6][7][8][9]. However, few reports have so far evaluated the treatment or outcomes of elderly patients.…”
Section: Discussionmentioning
confidence: 98%
“…As non-small cell lung cancer (NSCLC) is a common disease in the elderly population, the number of cases of NSCLC is increasing, with patients older than 80 years of age accounting for 14 % of all patients with lung cancer [2]. Although surgery is the best therapeutic modality for patients with early stages of NSCLC, recurrence has been reported to occur in 20-50 % of all cases [3][4][5][6][7][8][9]. According to the Japanese Lung Cancer Registry Study, tumor recurrence remains a major cause of postoperative death [10].…”
Section: Introductionmentioning
confidence: 99%